DEUTSCHE BANK AG\ - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$117,224
-9.8%
33,782
+20.9%
0.00%
Q2 2023$129,893
-14.5%
27,934
-15.0%
0.00%
Q1 2023$151,892
-17.8%
32,877
+43.7%
0.00%
Q4 2022$184,830
+88.6%
22,875
+29.2%
0.00%
Q3 2022$98,000
-9.3%
17,711
-14.2%
0.00%
Q2 2022$108,000
-44.6%
20,654
-13.2%
0.00%
Q1 2022$195,000
-77.1%
23,793
-58.4%
0.00%
Q4 2021$850,000
-19.3%
57,150
+2.5%
0.00%
Q3 2021$1,053,000
+0.2%
55,754
-1.4%
0.00%
-100.0%
Q2 2021$1,051,000
-60.5%
56,554
-51.6%
0.00%0.0%
Q1 2021$2,658,000
+4.7%
116,807
-0.1%
0.00%
-50.0%
Q4 2020$2,538,000
+1674.8%
116,894
+726.0%
0.00%
Q3 2020$143,000
+123.4%
14,152
+72.1%
0.00%
Q2 2020$64,000
+88.2%
8,223
+143.4%
0.00%
Q1 2020$34,000
-58.5%
3,379
-55.3%
0.00%
Q4 2019$82,000
+228.0%
7,559
+164.1%
0.00%
Q3 2019$25,000
-75.0%
2,862
-67.9%
0.00%
Q2 2019$100,000
-4.8%
8,906
-4.7%
0.00%
Q1 2019$105,000
+20.7%
9,349
-4.7%
0.00%
Q4 2018$87,0009,8150.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$27,149,00017.55%
Samsara BioCapital, LLC 1,675,579$24,933,0004.84%
AJU IB Investment Co., Ltd. 175,000$2,604,0003.63%
First Light Asset Management, LLC 2,246,588$33,429,0002.39%
Opaleye Management Inc. 680,000$10,118,0002.15%
FRAZIER MANAGEMENT LLC 1,776,479$26,434,0002.04%
Connective Portfolio Management, LLC 35,000$527,0000.93%
Parkman Healthcare Partners LLC 221,219$3,292,0000.73%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,437,795$36,274,0000.70%
Eventide Asset Management 2,708,975$40,310,0000.52%
View complete list of SUTRO BIOPHARMA INC shareholders